Intellia Therapeutics
NTLA
NTLA
290 hedge funds and large institutions have $1.16B invested in Intellia Therapeutics in 2024 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 126 increasing their positions, 66 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
290
Holders Change
+10
Holders Change %
+3.57%
% of All Funds
3.86%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
64
Increased
126
Reduced
66
Closed
49
Calls
$16.5M
Puts
$11.5M
Net Calls
+$4.96M
Net Calls Change
+$14.9M
Top Buyers
| 1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$26.9M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$29.1M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$20.3M |
| 4 |
4
Morgan Stanley
New York
|
$44.5M |
| 5 |
5
BlackRock
New York
|
$127M |
